📞 
— free, 24/7
— free, 24/7 — free, 24/7| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 100mcg | 6 inhalers | C$46.38 | C$278.25 Best Price Popular | |
| 100mcg | 3 inhalers | C$50.24 | C$150.71 | |
| 100mcg | inhaler | C$56.02 | C$56.02 |
Disclaimer: This page provides general information about Airomir for readers in Canada. It is not a substitute for medical advice from a healthcare professional. Check the official patient information leaflet and consult your doctor or pharmacist with any questions you have about your treatment.
Airomir is a medication that comes as an inhaler and contains salbutamol. It is used to help relieve breathing symptoms such as wheeze, chest tightness, and shortness of breath due to conditions like asthma or chronic obstructive pulmonary disease (COPD). It is taken by inhaling a measured dose through the mouthpiece of the inhaler.
Airomir acts quickly to relax the muscles around the airways, helping to open the airways and improve airflow. For many people, relief starts within minutes after use. It is known as a rescue inhaler because it is used to relieve acute symptoms when they occur.
The product is supplied as a pressurized metered-dose inhaler. Each actuation releases a specific dose into the lungs when you inhale. The exact number of puffs and how often you should use Airomir depends on your medical plan and the advice of your healthcare professional. Airomir may require a prescription depending on local rules in your area; follow your healthcare professional’s instructions and read the patient information leaflet that comes with the inhaler.
Keep Airomir out of reach of children and store it at room temperature in a dry place away from heat. If you have questions about whether Airomir is the right inhaler for you, ask your doctor or pharmacist. For personalized dosing and safety, always refer to the official leaflet and your healthcare professional’s guidance.
Airomir is used to relieve symptoms of bronchospasm, which can happen with asthma, COPD, or other lung conditions. It helps to open the airways and improve breathing during episodes of shortness of breath or wheezing.
Airomir can also be used to prevent exercise-induced bronchospasm if advised by a healthcare professional. Some people take it before physical activity to reduce the chance of symptoms during exercise.
Airomir is a rescue inhaler and is not a replacement for long-term controller medicines in asthma or COPD unless instructed by a clinician. Your treatment plan may include other medicines to control daily symptoms and reduce flare-ups. Always follow the advice of your healthcare professional and read the leaflet for full information.
If you have questions about whether Airomir is appropriate for your condition, discuss this with your doctor or pharmacist. In some places, Airomir may be prescribed or dispensed with varying rules; check local guidance and your prescription status with the pharmacy.
Airomir belongs to a class of medicines called beta-agonists. It works by relaxing the smooth muscles around the airways in the lungs. This relaxation opens the airways and makes it easier to breathe during breathing difficulties.
Airomir is a fast-acting inhaler. Many people notice relief within minutes of use, although the duration of action can vary. It is designed for short-term relief of symptoms and is not a long-term control medicine by itself.
Because Airomir acts quickly, it is important to use it as directed by your healthcare professional. Do not use Airomir more often than recommended, and do not rely on it alone to manage chronic symptoms without a broader asthma or COPD treatment plan. If you are unsure how Airomir fits into your overall treatment, ask your pharmacist or doctor for guidance.
Always read the official patient information leaflet for details about how Airomir works and how to use it safely. If you have questions about how this medicine works for you, talk to a healthcare professional.
Read the patient information leaflet that comes with your inhaler before first use and each time you refill. If you have any difficulty using the inhaler, ask your pharmacist for a demonstration or a spacer device if recommended by your clinician.
Airomir is used by inhaling through the mouthpiece. Do not shake the inhaler excessively; ensure it is ready for use according to the leaflet. Priming or preparation steps may be needed for a new inhaler or if it has not been used for some time; follow the specific instructions provided with your product.
Before inhaling, exhale fully. Place the mouth around the mouthpiece and press the canister while you inhale slowly and deeply. Hold your breath for a few seconds if possible, then exhale slowly. If your clinician has advised a second inhalation, wait a short period before taking the next puff.
After using Airomir, you may wish to rinse your mouth with water, especially if you use inhaled corticosteroids as part of your treatment plan. Keep the inhaler upright and store it as directed. Do not exceed the number of puffs prescribed by your clinician. If symptoms persist or worsen after use, seek medical advice promptly.
If you are unsure about any step in the inhaler technique, ask a healthcare professional for a demonstration. The official leaflets provide step-by-step instructions and safety information tailored to your product. If you are pregnant, breastfeeding, or taking other medicines, inform your clinician before using Airomir.
Airomir should not be used by people who have a known allergy to salbutamol or any ingredient in the inhaler. If you have ever had an allergic reaction to inhaled medicines, tell your doctor before using Airomir.
People with certain heart conditions, high blood pressure, irregular heart rhythms, or a history of tachycardia should use Airomir with caution and under medical supervision. If you have a heart condition or high blood pressure, discuss the risks and benefits with your doctor.
Airomir may interact with other medicines, including non-selective beta-blockers or some antidepressants. Inform your clinician about all medicines you are taking, including over‑the‑counter products and herbal supplements.
Pregnant or breastfeeding individuals should consult a healthcare professional to weigh the potential benefits and risks. If you are pregnant or planning pregnancy, speak with your obstetrician or family physician before using Airomir. This section does not replace medical advice from your clinician.
Airomir is intended for relief of acute symptoms. It should be used as part of a broader asthma or COPD management plan, not as the sole long‑term therapy. If you have a severe flare or your breathing does not improve after use, seek urgent medical help.
Paradoxical bronchospasm, although rare, is a possible reaction to inhaled beta-agonists. If you notice a sudden worsening of breathing after using Airomir, stop using it and seek medical attention.
Airomir can cause side effects such as trembling, nervousness, or increased heart rate in some people. If these effects are bothersome or persistent, contact your healthcare professional for advice.
Inform your doctor about all your medicines and health conditions before using Airomir. Some medicines can interact with Airomir and may require adjustments to your treatment plan. Store the inhaler as directed and replace it when advised by the leaflet or your pharmacist.
Common side effects may include tremor or shakiness, nervousness, headache, throat irritation, or coughing after inhalation. Some people notice a faster heartbeat or palpitations.
Less common effects can include dizziness, muscle cramps, or dry mouth. If you experience any persistent or troublesome side effects, contact your healthcare professional.
Seek urgent medical help if you notice signs of a serious allergic reaction, such as hives, swelling of the face or throat, or severe trouble breathing. If you have chest pain, fainting, or a very rapid heartbeat, seek medical attention promptly.
Not all side effects are listed here. For a full list, refer to the patient information leaflet that accompanies Airomir. If you have questions about side effects, ask your pharmacist or doctor.
Airomir can interact with other medicines. Tell your clinician about all medicines you take, including over‑the‑counter drugs and supplements. Some interactions may require changes to your treatment plan.
Medicines that affect heart rhythm or blood pressure, certain antidepressants, or other inhaled beta-agonists may influence how Airomir works. If you take non‑selective beta‑blockers, discuss risks and benefits with your doctor, as these can reduce the effect of Airomir or worsen symptoms in some people.
If you are using inhaled steroids or other inhaled therapies, your clinician may adjust your regimen to ensure safe and effective control of your symptoms. Do not start or stop other medicines without medical advice.
Always check with your pharmacist or doctor before combining Airomir with any other treatments. The official patient information leaflet provides details tailored to your inhaler product.
The safety of Airomir during pregnancy and while breastfeeding should be discussed with a healthcare professional. The decision to use Airomir during pregnancy is based on whether the potential benefit to the mother outweighs any possible risk to the developing fetus.
If you are pregnant or planning pregnancy, inform your clinician about your condition and any medicines you are taking. Do not stop prescribed treatments without discussing them with your doctor.
Breastfeeding individuals should talk with their healthcare provider about the best treatment options, as some medicines can pass into breast milk. Your clinician can help determine a safe plan for you and your baby.
Always follow the advice of your healthcare professional and refer to the official leaflet for safety information specific to your product.
Airomir is designed to work quickly for many people, often providing relief within minutes of use. The onset and duration can vary from person to person. If symptoms persist, contact a healthcare professional for guidance.
Airomir is a rescue inhaler meant to relieve symptoms during an attack. Use it as directed by your healthcare professional. If you do not feel better after using Airomir, seek urgent medical help.
If you forget a planned dose, use Airomir as soon as you remember, unless it is almost time for your next scheduled dose. Do not double the dose unless advised by your clinician.
Airomir can be used with other asthma or COPD medicines, but tell your doctor about all medicines you take. Some combinations may require adjustments to your treatment plan. Do not change therapies on your own.
Airomir is used in many children under medical supervision. Dosing and inhaler technique may differ for children. Parents and caregivers should be shown how to use the inhaler correctly, and a clinician should monitor the child’s response.
Airomir may require a prescription depending on local rules. Check with your pharmacy or healthcare provider about how Airomir is dispensed in your area.
If you suspect you have used more Airomir than recommended, contact a healthcare professional for advice. Symptoms such as tremor or rapid heartbeat may occur, and severe symptoms warrant medical attention.
Airomir is a rescue inhaler used for short-term relief. Do not change any long-term asthma or COPD therapies without discussing it with your doctor. Your clinician can advise on how and when to adjust your treatment plan.
Store Airomir at room temperature in a dry place, away from heat and moisture. Keep it out of reach of children. Do not use Airomir after the expiry date printed on the inhaler or packaging.
If Airomir does not provide relief or your symptoms become worse, seek medical help promptly. Do not rely on Airomir alone for ongoing control of symptoms; a clinician may need to reassess your treatment plan.
Airomir is intended for short-term relief of acute symptoms. It is important to follow a broader treatment plan for long-term control as advised by your clinician. If you have concerns about long-term use, discuss them with your doctor or pharmacist.
The information in this page draws on the Airomir product leaflet (manufacturer-provided patient information) and general clinical guidance for inhaled salbutamol products. For exact dosing, instructions, and safety information, always refer to the official leaflet that accompanies your inhaler and consult your healthcare professional. Health authorities in Canada provide guidance through official channels and your pharmacist can explain how Airomir is used within your local treatment guidelines.
14–21 days. Free from C$276.06 .
5–9 days. C$41.41
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
